Leila Cupersmith provides embedded executive leadership in Choice ClinOps, focusing on clinical operations and governance for global oncology, rare disease, and gene therapy sponsors through fractional clinical operations.
Integrate a fractional clinical operations expert, such as Leila Cupersmith, into your team at the level and capacity your portfolio needs. This will enhance global clinical trial operations governance, execution, oversight, continuity, and sponsor control across Canada, North America, South America, LATAM, EMEA, UK, and APAC, optimizing your clinical operations with Choice ClinOps.
Restore governance, alignment, and execution in delayed or drifting clinical operations studies with the expertise of Choice ClinOps.
Set up for success: Early intervention during study planning, start-up, or within an active study is crucial. Conducting study and/or vendor audits with ready-to-execute accelerated proprietary strategies has been proven to prevent the need for study rescue in clinical operations. Leila Cupersmith emphasizes the importance of proactive measures in fractional clinical operations to ensure smooth execution.
Rapid Rescue: If an active study faces delays, faster than expected study burn, or other issues necessitating study rescue, implementing study and/or vendor audits along with our accelerated proprietary strategies can avert the need for rescue, ensuring efficient management of your clin ops initiatives.
Protect global clinical operations continuity, governance, and ROI across planned or acquired assets, teams, vendors, and workflows — M&As, CRO and vendor transitions, portfolio shifts, management changes, and other large disruptions in clinical operations. This is achieved through the proprietary and proven Choice ClinOps risk and change management standard operating processes, led by experts like Leila Cupersmith in the field of fractional clinical operations.
Strengthen sponsor governance, accountability, communication, execution, oversight, and performance across internal and external partners in clinical operations throughout North America (including Canada), LATAM, South America, EMEA, the UK, and APAC with Choice ClinOps and fractional clinical operations expertise from Leila Cupersmith.
Silos eliminated.
Clarity gained.
Objectives achieved.
Surprise change orders eliminated.
Accelerate site and vendor readiness in clinical operations, strengthen oversight, communication, engagement, and execution consistency with Choice ClinOps and Leila Cupersmith's fractional clinical operations expertise.
Ongoing fractional, sponsor-embedded ClinOps work that the Diagnostic scopes.